These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9886310)

  • 21. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyskeratosis congenita: report of two cases with distinct clinical presentations.
    Demirgüneş FE; Elçin G; Sahin S
    Turk J Pediatr; 2008; 50(6):604-8. PubMed ID: 19227430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile Idiopathic Inflammatory Myopathy in a Patient With Dyskeratosis Congenita Due to C16orf57 Mutation.
    Kilic SS; Cekic S
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):e75-7. PubMed ID: 26535771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyskeratosis congenita is a chromosomal instability disorder.
    Dokal I; Luzzatto L
    Leuk Lymphoma; 1994 Sep; 15(1-2):1-7. PubMed ID: 7858487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.
    Jongmans MC; Verwiel ET; Heijdra Y; Vulliamy T; Kamping EJ; Hehir-Kwa JY; Bongers EM; Pfundt R; van Emst L; van Leeuwen FN; van Gassen KL; Geurts van Kessel A; Dokal I; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
    Am J Hum Genet; 2012 Mar; 90(3):426-33. PubMed ID: 22341970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyskeratosis congenita.
    Dokal I
    Hematology Am Soc Hematol Educ Program; 2011; 2011():480-6. PubMed ID: 22160078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research progress of dyskeratosis congenita].
    Wang F; Du YQ; Gong W; Sun CK; Zeng X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Feb; 54(2):130-134. PubMed ID: 30695916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad.
    Wang L; Li J; Xiong Q; Zhou YA; Li P; Wu C
    Front Pediatr; 2022; 10():834268. PubMed ID: 35463902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyskeratosis congenita: unusual presenting features within a kindred.
    Forni GL; Melevendi C; Jappelli S; Rasore-Quartino A
    Pediatr Hematol Oncol; 1993; 10(2):145-9. PubMed ID: 8318369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiologic heterogeneity in dyskeratosis congenita.
    Pai GS; Morgan S; Whetsell C
    Am J Med Genet; 1989 Jan; 32(1):63-6. PubMed ID: 2705484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dyskeratosis congenita: three additional families show linkage to a locus in Xq28.
    Arngrimsson R; Dokal I; Luzzatto L; Connor JM
    J Med Genet; 1993 Jul; 30(7):618-9. PubMed ID: 8105085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to androgen therapy in patients with dyskeratosis congenita.
    Khincha PP; Wentzensen IM; Giri N; Alter BP; Savage SA
    Br J Haematol; 2014 May; 165(3):349-57. PubMed ID: 24666134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita.
    Tummala H; Walne A; Buccafusca R; Alnajar J; Szabo A; Robinson P; McConkie-Rosell A; Wilson M; Crowley S; Kinsler V; Ewins AM; Madapura PM; Patel M; Pontikos N; Codd V; Vulliamy T; Dokal I
    Am J Hum Genet; 2022 Aug; 109(8):1472-1483. PubMed ID: 35931051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC).
    Heiss NS; Mégarbané A; Klauck SM; Kreuz FR; Makhoul E; Majewski F; Poustka A
    Genet Couns; 2001; 12(2):129-36. PubMed ID: 11491307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.
    Vuong LG; Hemmati PG; Neuburger S; Terwey TH; Vulliamy T; Dokal I; le Coutre P; Dörken B; Arnold R
    Acta Haematol; 2010; 124(4):200-3. PubMed ID: 21042011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.